Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus: a Multicenter, Open-label, Randomized, Controlled Trial (DIGNITY Trial)

NCT05366868 is registered in ClinicalTrials.gov with National Center for Global Health and Medicine, Japan as lead sponsor.

NCT NCT05366868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05366868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus: a Multicenter, Open-label, Randomized, Controlled Trial (DIGNITY Trial)
Lead sponsor
National Center for Global Health and Medicine, Japan
Phase
Phase 4
Overall status
Active, not recruiting
Start date
May 26, 2022
Completion date
March 31, 2027
Enrollment
567 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2